Most Read Articles
21 Nov 2020
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
Elvira Manzano, 12 May 2020
After months of work disruption, profound worrying, social distancing, and isolation, SARS-CoV-2* still rages on, unyielding to human interventions.
Rachel Soon, 05 Dec 2020

The Malaysian National Immunisation Programme (NIP) will now include a hexavalent combination DTaP-IPV-HiB-HepB vaccine and a pneumococcal vaccine.

Elvira Manzano, 12 Dec 2020
Having asthma or allergy does not make COVID-19 severe, a new study presented at ACAAI 2020 has shown.

COVID-19 recommendations in 23 languages for cancer patients

Christina Lau
07 Jul 2020

Comprehensive recommendations on coronavirus disease 2019 (COVID-19) for cancer patients have become available following review of guidelines from 63 national/international oncology societies. [Lancet Oncol 2020, doi: 10.1016/S1470-2045(20)30278-3]

The recommendations, available in 23 languages, including Chinese, English, Japanese and Urdu, can be downloaded from websites of the European Cancer Patients Coalition and Hellenic Cancer Federation. [https://ecpc.org/covid-19-information/]

The recommendations cover six main areas:

1)      General considerations for cancer patients during the COVID-19 pandemic

2)      Protocols or special measures for cancer patients to avoid COVID-19 infection

3)      Action to take when someone is symptomatic

4)      Guidance on managing anxiety and stress

5)      Building trust with physicians to enhance patients’ confidence and compliance

6)      Procedures at cancer centres

Professional guidance has become highly important during this time as patients with cancer – who are at high risk of serious illness and death from COVID-19 – are facing unprecedented circumstances with concerns that may interfere with their continuity of care. The recommendations are developed to help these patients reduce the risk of contracting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); promote their safety, treatment and compliance; and ameliorate their stress and anxiety.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
21 Nov 2020
Ivermectin confers benefits in the treatment of COVID-19, with a recent study showing that its use helps reduce the risk of death especially in patients with severe pulmonary involvement.
Elvira Manzano, 12 May 2020
After months of work disruption, profound worrying, social distancing, and isolation, SARS-CoV-2* still rages on, unyielding to human interventions.
Rachel Soon, 05 Dec 2020

The Malaysian National Immunisation Programme (NIP) will now include a hexavalent combination DTaP-IPV-HiB-HepB vaccine and a pneumococcal vaccine.

Elvira Manzano, 12 Dec 2020
Having asthma or allergy does not make COVID-19 severe, a new study presented at ACAAI 2020 has shown.